Research & Development
Our current initiatives reflect our commitment to solving critical
challenges in drug discovery, diagnostics, and personalized medicine.
Current Projects
CTC Organoid
Development
Leveraging circulating tumor cells (CTCs) to create patient-specific organoid models for cancer research
and treatment optimization.
Spatial
Transcriptomics
Collaboration
Partnering to integrate spatial transcriptomics with organoid technology, enabling high-resolution molecular analysis for drug discovery and disease understanding.
Rare Genetic
Disorder Models
Disorder Models
Developing organoid models for rare diseases using CRISPR-Cas9 technology, opening new avenues for treatment development and drug repurposing.
Scalable Organoid
Production Platforms
Production Platforms
Refining our mass production processes to enhance reproducibility and scalability, ensuring reliable supply
for research and clinical applications.